Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III...
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
About this item
Full title
Author / Creator
Yamamoto, Yutaka , Iwata, Hiroji , Taira, Naruto , Masuda, Norikazu , Takahashi, Masato , Yoshinami, Tetsuhiro , Ueno, Takayuki , Toyama, Tatsuya , Yamanaka, Takashi , Takano, Toshimi , Kashiwaba, Masahiro , Tsugawa, Koichiro , Hasegawa, Yoshie , Tamura, Kenji , Tada, Hiroshi , Hara, Fumikata , Fujisawa, Tomomi , Niikura, Naoki , Saji, Shigehira , Morita, Satoshi , Toi, Masakazu and Ohno, Shinji
Publisher
Tokyo: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
No standard options existed for human epidermal growth factor receptor 2 (HER2)‐positive advanced breast cancer that progresses after second‐line trastuzumab emtansine therapy before 2020. The purpose of this study was to examine the efficacy of pertuzumab retreatment after disease progression following pertuzumab‐containing therapy for HER2‐positi...
Alternative Titles
Full title
Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
Authors, Artists and Contributors
Author / Creator
Iwata, Hiroji
Taira, Naruto
Masuda, Norikazu
Takahashi, Masato
Yoshinami, Tetsuhiro
Ueno, Takayuki
Toyama, Tatsuya
Yamanaka, Takashi
Takano, Toshimi
Kashiwaba, Masahiro
Tsugawa, Koichiro
Hasegawa, Yoshie
Tamura, Kenji
Tada, Hiroshi
Hara, Fumikata
Fujisawa, Tomomi
Niikura, Naoki
Saji, Shigehira
Morita, Satoshi
Toi, Masakazu
Ohno, Shinji
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9459345
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9459345
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/cas.15474
